GlaxoSmithKline plc (LSE:GSK) confirmed that consideration is being given to a potential transaction that includes a merger of GlaxoSmithKline Consumer Healthcare Limited (BSE:500676). Majority of Horlicks and other GlaxoSmithKline nutrition products sales are generated in India by GlaxoSmithKline Consumer Healthcare Limited.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,774 GBX | -0.20% | -0.03% | +22.36% |
05-27 | US, European nations consider vaccinating workers exposed to bird flu | RE |
05-24 | British Stocks Extend Losing Streak Amid Retail Sales Slump | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.36% | 92.44B | |
+38.51% | 727B | |
+31.74% | 594B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.44% | 205B | |
-5.97% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- GSK Says Considering Potential Deal Including Merger Of Its Consumer Healthcare Unit